Most frequent complaints reported(multiple complaints per patient are possible)

Adverse effect may be due to disease and/or other underlying condition and medication/treatment may not be causative factor

DRUG RATING DETAILS (RANK BASED ON RATINGS OF SIMILAR DRUGS; SEE TABLE AT BOTTOM)

Drug Brand Name	Zolinza
Drug Substance/Generic Name	vorinostat
Number of Patients Complaining	1,247
Serious Reactions to Substance	1,302
Non Serious Reactions to Substance	137
Substance Not Effective Complaints	24
At-Ray Ratio (NSR/SR); Safety indicator, higher is safer	0.11
PP Ratio (Patients Complaining/Not Effective), higher is more effective	51.96
Drug Rating = PP Ratio* At-Ray Ratio	0.81

Summary (from Wikipedia)

Indications and Usage (from FDA label)

1 INDICATIONS AND USAGE ZOLINZA ® is indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma who have progressive, persistent or recurrent disease on or following two systemic therapies. ZOLINZA is a histone deacetylase (HDAC) inhibitor indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL) who have progressive, persistent or recurrent disease on or following two systemic therapies. (1)

Copyright for images below belongs to manufacturer mentioned in label, presented for information only

Other antineoplastic agents

(28) Similar Drugs to Zolinza ; Comparison Table Below
(Best drugs have high rating/ranking,high safety ratio and high effectivity ratio)

Brand Name (Click for details)	Active Ingredient	Drug ATC Class	Price Found (US $)	OVERALL Drug Rating